1. Novavax Faces Boardroom Rebellion as Shah Capital Moves to Vote Against Nominees
Novavax stock is rising on the back of a brewing internal power struggle. The catalyst is a report that Shah Capital, a significant shareholder, intends to vote against the company's board nominees. This move signals a direct challenge to the current leadership's strategy and governance at a critical juncture for the v...